Coghill Capital Management Maintains Stake In General Moly, Inc. (GMO), No Longer Activist

Page 2 of 2

On the financial front, General Moly, Inc. (NYSEMKT:GMO) has a market cap of $48.86 million and its shares are trading at $0.51 per share. It has been a difficult year for the company, with its shares declining by 16.23% year-to-date. Further, the shares of the molybdenum production company have declined by 53.96% in the past 12 months. General Moly reported its first quarter 2015 financial results on May 4, 2015, posting net operating expenses of $3.10 million. Its net loss for the quarter stood at $3.78 million, surpassing the loss of $2.36 million from the same quarter last year. The company did not report its revenue figures for the quarter in its report. At the end of the first quarter, General Moly, Inc. (NYSEMKT:GMO) had net cash of $16 million, higher than the net cash of $13 million quarter-over-quarter.

While talking about hedge fund investments, General Moly, Inc. (NYSEMKT:GMO) has attracted investments from the likes of Israel Englander’s Millennium Management and Ken Griffin’s Citadel Investment Group. Mr. Englander held 132,400 shares of the mineral company at the end of the first quarter, with a market value of $68,000. Ken Griffin reported ownership of 38,895 shares valued at $20,000. Jim Simons’ Renaissance Technologies was among the hedge funds in our database closing their position in General Moly, Inc. (NYSEMKT:GMO) in the first quarter. Mr. Simons reported owning $6,000 worth of stock, 11,400 shares total, at the end of the fourth quarter of 2014.

Disclosure: None

Page 2 of 2